ALC.SW Alcon Inc. (SIX) closes CHF62.56 on 11 Mar 2026: watch analyst targets

ALC.SW stock closed the Swiss session at CHF62.56 on 11 Mar 2026 with 970,451 shares traded, ranking it among the most active listings on SIX today. The stock finished down 0.22% on the day after an intraday high of CHF63.52 and a low of CHF62.18, while the 50-day average sits at CHF63.15 and the 200-day at CHF64.76. Traders flagged volume below the three‑month average, and valuation metrics such as a PE of 40.95 and EPS 1.54 shaped much of the session’s debate about near-term upside and risks for Alcon Inc.

ALC.SW stock: session summary, price and liquidity

Alcon Inc. (ALC.SW) closed at CHF62.56 on SIX in Switzerland after trading between CHF62.18 and CHF63.52. Volume of 970,451 shares was below the average daily volume of 1,093,286, giving a relative volume of 0.63, which suggests institutional traders were selective today.

ALC.SW stock financials and valuation

Alcon’s trailing EPS is 1.54 and the current PE is 40.95, well above the Swiss healthcare sector average PE of 30.19, highlighting premium valuation pressure. The company shows a strong balance sheet with a current ratio of 2.12 and debt to equity of 0.26, while key ratios include price to book 1.80 and free cash flow yield of 4.33%.

ALC.SW stock technicals and trading signals

Technical indicators for ALC.SW show neutral momentum with RSI 47.83 and MACD histogram slightly negative at -0.21. Bollinger bands place the middle band at CHF63.56, implying limited daily volatility, and ATR of 1.74 points to moderate price swings for short-term traders.

Meyka AI rates ALC.SW with score and model forecast

Meyka AI rates ALC.SW with a score of 75.93 out of 100, grade B+ with a suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of CHF56.65, which implies an approximate -9.42% downside from the current CHF62.56. Forecasts are model-based projections and not guarantees; these grades are not guaranteed and we are not financial advisors.

Sector context, risks and opportunities for ALC.SW stock

Alcon operates in Healthcare, Medical – Instruments & Supplies, where the sector shows average PE 30.19 and defensive demand. ALC.SW faces headwinds from valuation premium and inventory days at 186.92, but benefits from improving operating cash flow growth and product mix across Surgical and Vision Care segments.

Price targets, analyst view and trading strategy for ALC.SW

In current market analysis we frame practical price levels: a conservative target CHF55.00, a base case CHF70.00, and a bullish scenario CHF80.00. Use tight risk controls given PE 40.95 and upcoming earnings announcement on 2026-05-05. Traders watching most active movers should track volume above 1.09M and intraday breaks of CHF63.52 for momentum entries.

Final Thoughts

Key takeaways on ALC.SW stock: Alcon closed the session at CHF62.56 on 11 Mar 2026 with 970,451 shares traded, making it one of the most active names on SIX today. Valuation remains a central theme — a PE of 40.95 sits above the healthcare sector average of 30.19, and inventory days of 186.92 signal operational working capital to monitor. Meyka AI’s model projects a yearly price of CHF56.65, implying roughly -9.42% from the current price; this frames a cautious near-term outlook against a longer-term growth profile. Our Meyka AI grade of B+ (BUY) balances quality cash flows and solid margins with stretched valuation. For active traders, watch volume exceeding 1.09M and a clear earnings update on 2026-05-05 for directional bias. Remember, model forecasts are projections and not guarantees, and this report is informational, not investment advice. For official filings and company details see Alcon and market context in recent coverage like the WSJ report. Meyka AI provides this AI-powered market analysis to help frame active trading decisions.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.